Ronald Renaud

Ronald Renaud

Chief Executive Officer bij CEREVEL THERAPEUTICS HOLDINGS, INC.

Vermogen: 10 M $ op 29-02-2024

55 jaar
Health Technology
Finance
Consumer Services

Profiel

Ronald C.
Renaud
is a businessperson who has been at the helm of 6 different companies and presently occupies the position of Independent Chairman at Axial Therapeutics, Inc., President.
Chief Executive Officer & Director at Cerevel Therapeutics Holdings, Inc., Advisor at Atlas Venture Advisors, Inc. and Senior Advisor at Bain Capital Life Sciences LP.
He is also on the board of St. Anselm College, Jnana Therapeutics, Inc. and Upstream Bio, Inc. and Member-Overseers Board at Newton-Wellesley Hospital Corp.
In his past career he held the position of Chairperson of the Board at Atara Biotherapeutics, Inc., Chairman for Ikena Oncology, Inc., Managing Director at Soundview Capital Management Corp., Partner at Bain Capital Holdings LP, Chairman & Chief Executive Officer of Translate Bio, Inc., President, CEO, CFO & Director at Idenix Pharmaceuticals LLC, Chief Financial Officer, Treasurer & Senior VP for Keryx Biopharmaceuticals, Inc., Managing Director at Bear, Stearns & Co., Inc., Managing Director at Charles Schwab & Co., Inc., Managing Director at Bear, Stearns & Co., Inc., Analyst at JPMorgan Securities LLC and Research Analyst at Schwab SoundView Capital Markets.
Ronald C.
Renaud
received an undergraduate degree from St. Anselm College and an MBA from USC Marshall School of Business.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
19-01-2024 244 309 ( 0.13% ) 10 M $ 29-02-2024

Actieve functies van Ronald Renaud

BedrijvenFunctieBegin
CEREVEL THERAPEUTICS HOLDINGS, INC. Chief Executive Officer 12-06-2023
Chairman -
Director/Board Member -
Director/Board Member -
Consultant / Advisor -
Corporate Officer/Principal -
St. Anselm College Director/Board Member -
Consultant / Advisor 01-06-2023
Alle actieve functies van Ronald Renaud

Eerdere bekende functies van Ronald Renaud

BedrijvenFunctieEinde
Private Equity Investor 01-06-2023
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ervaring van Ronald Renaud in detail bekijken

Opleiding van Ronald Renaud

St. Anselm College Undergraduate Degree
USC Marshall School of Business Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Ronald Renaud in detail bekijken

Connecties

100 +

Eerstegraads connecties

24

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven6
CHIMERIX, INC.

Health Technology

PTC THERAPEUTICS, INC.

Health Technology

AKEBIA THERAPEUTICS, INC.

Health Technology

IKENA ONCOLOGY, INC.

Health Technology

CEREVEL THERAPEUTICS HOLDINGS, INC.

Health Technology

ATARA BIOTHERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit16

Finance

Health Technology

Health Technology

Finance

Finance

Health Technology

Schwab SoundView Capital Markets

Finance

Finance

Health Services

American Liver Foundation of Northern California

Finance

Finance

Health Technology

Miscellaneous

Health Technology

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Ronald Renaud